We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

NeoChord TACT Post-Market Surveillance Registry

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01784055
First Posted: February 5, 2013
Last Update Posted: August 30, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
NeoChord
January 31, 2013
February 5, 2013
August 30, 2016
March 2013
July 2016   (Final data collection date for primary outcome measure)
Procedure Success [ Time Frame: The patient will be evaluated from the procedure through the hospital discharge. Approximately 1 day. ]
To describe the rate of subjects with at least one neochord placed using the DS1000 System AND a reduction in mitral regurgitation ≤ 2+ at the time of the procedure
Same as current
Complete list of historical versions of study NCT01784055 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
NeoChord TACT Post-Market Surveillance Registry
Post-Market Surveillance Registry for the NeoChord DS1000
To monitor the long-term performance of the CE Marked NeoChord Artificial Chordae Delivery System
Not Provided
Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
1 Year
Not Provided
Non-Probability Sample
Patients with Grade 3+ or 4+ mitral valve regurgitation who are candidates for surgical mitral valve repair or replacement
  • Mitral Valve Insufficiency
  • Heart Valve Diseases
  • Heart Diseases
  • Cardiovascular Diseases
Not Provided
Not Provided
Not Provided
 
Completed
126
July 2016
July 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Grade 3+ or 4+ mitral valve regurgitation

Exclusion Criteria:

  • Heavily calcified valves
  • Valvular retraction with severely reduced mobility
  • Active bacterial endocarditis
  • Complex mechanism of MR (leaflet perforation, etc.)
  • Significant tethering of leaflets
  • Inflammatory valve disease
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
France,   Germany,   Italy,   Lithuania,   Switzerland
 
 
NCT01784055
800001-001
No
Not Provided
Not Provided
NeoChord
NeoChord
Not Provided
Study Chair: Joerg Seeberger, MD Leipzig University
NeoChord
August 2016